A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
Clinical trial NCT04088396 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04088396
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2026-10-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.